Micheler Richardson

Micheler Richardson is a Professor of Biology and Director of the Cancer Research Program at North Carolina Central University (NCCU), with an adjunct appointment as Adjunct Assistant Professor in Pharmacology at UNC-Chapel Hill. He previously held faculty roles at Duke University Medical Center and Meharry Medical College.

• Education: B.S., M.S., and Ph.D. in Biology from Universitat Autonoma of Barcelona; postdoctoral training at Northwestern University.

His research focuses on chemoattractant and chemokine receptors, particularly their roles in immune cell signaling and cancer progression. He has authored over 60 publications and leads a multidisciplinary team targeting prostate, breast, and lung cancers through receptor desensitization and cross-talk mechanisms.

His recent work (2012-2013) highlights the interplay between G-protein-coupled receptor kinases (GRKs), β-arrestin, and chemokine receptors in modulating angiogenesis, tumor metastasis, and protein engineering strategies. This aligns with broader interests in signal transduction and inflammatory responses in cancer contexts.

Dr. Richardson's lab at the Julius L. Chambers Biomedical/Biotechnology Research Institute (JLC-BBRI) partners with UNC Lineberger and Duke University Comprehensive Cancer Centers for community outreach, student training, and translational research.